NCF International

Digitalisation, greener packaging, energy-efficient manufacturing and alternative testing methods are among the technologies that could accelerate sustainability across the pharmaceutical value chain, according to a report from a March 2026 workshop organised by the European Medicines Agency

EMA has published a new Q&A guideline focused on GMP and quality aspects related to 3D printing in pharmaceutical manufacturing. The document applies to human and veterinary medicines as well as investigational products

Two emerging areas have been highlighted through EMA’s Horizon Scanning activities. Targeted protein degradation (TPD) seeks to remove disease-associated proteins by exploiting the cell’s own degradation pathways, while research, development and manufacturing in microgravity could open the way to medicinal products with improved properties

The European Research Council has announced the results of the 2025 Advanced Grants competition, allocating a total of €838 million to support frontier research projects led by established scientists across Europe.The grants are designed to enable ambitious, high-risk, high-gain research that could lead to major scientific breakthroughs